Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04846738
Other study ID # IRBN282021/CHUSTE
Secondary ID
Status Completed
Phase
First received
Last updated
Start date April 1, 2021
Est. completion date August 14, 2022

Study information

Verified date April 2023
Source Centre Hospitalier Universitaire de Saint Etienne
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Transcranial Doppler is performed daily in Intensive Care Unit in brain damaged patients. For a few years now, the measurement of the photomotor reflex by quantitative Pupillometry has been routinely performed in Intensive Care Units. The objective of this work is to see if Transcranial Doppler recorded parameters and Pupillary parameters are correlated to the neurological prognosis evaluated at 9 months by the Modified Rankin Score (mRS) and the Glasgow Outcome Scale Extended (GOS-E).


Recruitment information / eligibility

Status Completed
Enrollment 73
Est. completion date August 14, 2022
Est. primary completion date July 14, 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - All brain damaged patients (stroke or head trauma) - Admitted to Intensive Care Unit since December 1, 2020 Exclusion Criteria: - Refusal by the patient or his/her legal representative. - Benefiting from legal protection

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Transcranial Doppler
This device measures Mean Systolic Velocity (VMS), Tele-Diastolic Velocity (TDV) and Pulsatility Index (PI),
Pupillometry.
This device measures the photomotor reflex (basic pupil diameter, percentage of variation, latent and slope of the standard photomotor reflex)

Locations

Country Name City State
France CHU Saint-Etienne Saint-Étienne

Sponsors (1)

Lead Sponsor Collaborator
Centre Hospitalier Universitaire de Saint Etienne

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Modified Rankin Score (mRS) (0-5) Modified Rankin Score (mRS) measures the degree of disability following a stroke in a patient (level 0 for patients with no symptoms to level 5 for patients with major disability and total dependency).. Year: 1
Primary Glasgow Outcome Scale Extended (GOS-E) (1-8) Glasgow Outcome Scale Extended (GOS-E) measure the impact of brain injured (minimum at 1 (Dead) and maximum at 8 (Upper Good Recovery). Year: 1
Secondary Mean Systolic Velocity (VMS) Measured by Transcranial Doppler right and left. At inclusion
Secondary Intra-Cranial Pressure (ICP) Collect on medical file. At inclusion
Secondary Pulsatility Index (PI) Measured by Transcranial Doppler right and left. At inclusion
Secondary Tele-Diastolic Velocity (TDV) Measured by Transcranial Doppler right and left. At inclusion
Secondary Basic pupil diameter Measured by Pupillometry right and left At inclusion
Secondary Percentage of variation of the pupil diameter Measured by Pupillometry right and left At inclusion
Secondary Latent and slope of the standard photomotor reflex Measured by Pupillometry right and left At inclusion
Secondary Tissue Partial Oxygen Pressure (PtiO2) Collect on medical file. At inclusion
Secondary Bispectral Index (BIS) Collect on medical file. BIS is a reflection of the depth of hypnosis At inclusion
Secondary Richmond Agitation-Sedation Scale (RASS) Richmond Agitation-Sedation Scale (RASS) is a symmetrical rating, with positive values for agitation and negative values for the level of consciousness around a point 0 corresponding to a calm and awake patient.
Collect on medical file.
At inclusion
Secondary Heart rate Collect on medical file. At inclusion
Secondary Blood pressure Collect on medical file. At inclusion
Secondary Natremia (mmol/l) Collect on medical file. At inclusion
Secondary Glycemia (mmol/l) Collect on medical file. At inclusion
See also
  Status Clinical Trial Phase
Active, not recruiting NCT04546737 - Study of Morphological, Spectral and Metabolic Manifestations of Neurological Complications in Covid-19 Patients N/A
Recruiting NCT05134116 - SafeBoosC III Two-year Follow-up
Completed NCT03712839 - Cognitive-functional Evaluation of Anosognosia
Completed NCT03958487 - An Executive/Monitoring Treatment Protocol on Everyday Life Activities N/A
Recruiting NCT06083233 - Role of Brain Specific Biomarkers in Hydrocephalus N/A
Recruiting NCT05692804 - Evaluation of Neuronal Damage in Patients Undergoing Robot-assisted Laparoscopic Radical Prostatectomy With Biomarkers
Recruiting NCT06027645 - Early Intervention Based on Neonatal Crawling in Very Premature Infants at Risk For Neurodevelopmental Disorder N/A
Completed NCT04052087 - Cross-cultural Adaptation to the Spanish Population and Validation of the BESTest and Mini-BESTest
Completed NCT01076257 - Efficacy of Modified Constraint-induced Movement Therapy in Children With Brain Damage N/A
Recruiting NCT03191409 - Interaction Research on Cognitive Impairment and Emotional Disorder in End-stage Renal Disease N/A
Completed NCT03823430 - Pupillometry : Predictive Indicator in External Ventricular Drain Clamping ?
Enrolling by invitation NCT05864677 - Cerebrolysin in Prevention of Postoperative Delirium in Cardiac Surgery N/A
Completed NCT04368052 - Liver Transplant Does it Affect the Brain N/A
Completed NCT04419818 - A Neuropsychological Test Battery for the Assessment of Time Deficits
Completed NCT04373837 - Rehabilitation Treatment of Time Deficits in Brain-damaged Patients N/A
Recruiting NCT05399602 - The Role of Neurofilament Light (NfL) in Patients With Hydrocephalus N/A
Terminated NCT03827421 - Junior Emergency Physician Learning Curve to Perform Transcranial Doppler on Brain-damage Patients
Recruiting NCT03344731 - Cognitive Abilities in Brain Damaged Patients N/A